Mallon Mark 4
4 · NEOGENOMICS INC · Filed Apr 21, 2021
Insider Transaction Report
Form 4
Mallon Mark
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-19+151,016→ 151,016 totalExercise: $49.34Exp: 2028-04-19→ Common Stock (151,016 underlying) - Award
Common Stock
2021-04-19+55,736→ 55,736 total
Footnotes (1)
- [F1]On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.